Occudo Quantitative Strategies LP Purchases Shares of 5,870 ICU Medical, Inc. (NASDAQ:ICUI)

Occudo Quantitative Strategies LP purchased a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 5,870 shares of the medical instruments supplier's stock, valued at approximately $911,000.

Several other large investors have also recently made changes to their positions in ICUI. Arizona State Retirement System increased its position in shares of ICU Medical by 1.0% in the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock valued at $1,044,000 after buying an additional 65 shares in the last quarter. Huntington National Bank increased its position in shares of ICU Medical by 6.2% in the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock valued at $218,000 after buying an additional 82 shares in the last quarter. Equitable Trust Co. increased its position in shares of ICU Medical by 1.6% during the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after purchasing an additional 84 shares in the last quarter. LPL Financial LLC increased its position in shares of ICU Medical by 2.0% during the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after purchasing an additional 93 shares in the last quarter. Finally, Alliancebernstein L.P. increased its position in shares of ICU Medical by 0.5% during the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock worth $4,051,000 after purchasing an additional 136 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Stock Performance

Shares of ICUI stock traded down $1.65 during trading hours on Monday, hitting $139.73. The stock had a trading volume of 65,639 shares, compared to its average volume of 276,279. The stock's 50 day moving average is $140.85 and its 200 day moving average is $153.84. ICU Medical, Inc. has a twelve month low of $100.91 and a twelve month high of $196.26. The firm has a market capitalization of $3.44 billion, a PE ratio of -30.48 and a beta of 0.87. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 EPS for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. The company had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. ICU Medical's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.96 earnings per share. As a group, research analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on ICUI shares. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a research note on Sunday. Raymond James decreased their price target on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a research note on Friday, May 9th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Finally, KeyCorp decreased their target price on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. One analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $192.67.

Insider Transactions at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 5,555 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $135.55, for a total value of $752,980.25. Following the transaction, the chief operating officer now directly owns 2,389 shares of the company's stock, valued at $323,828.95. This represents a 69.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director David C. Greenberg sold 1,942 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $143.66, for a total value of $278,987.72. Following the sale, the director now owns 6,760 shares of the company's stock, valued at approximately $971,141.60. The trade was a 22.32% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,053 shares of company stock worth $2,077,027. 1.50% of the stock is currently owned by corporate insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.